Skip to main content
David Fleischer, MD, Allergy & Immunology, Aurora, CO, Children's Hospital Colorado

DavidMFleischerMD

Allergy & Immunology Aurora, CO

Pediatric Asthma & Allergic Conditions

Professor of Pediatrics and Section Head, Children's Hospital Colorado, University of Colorado Denver School of Medicine

Dr. Fleischer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Fleischer's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Allergy and Immunology, 2002 - 2005
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Pediatrics, 1997 - 2000
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1997

Certifications & Licensure

  • NM State Medical License
    NM State Medical License 2021 - 2027
  • MT State Medical License
    MT State Medical License 2021 - 2026
  • CO State Medical License
    CO State Medical License 2005 - 2025
  • NV State Medical License
    NV State Medical License 2021 - 2025
  • WA State Medical License
    WA State Medical License 2024 - 2025
  • UT State Medical License
    UT State Medical License 2021 - 2024
  • AZ State Medical License
    AZ State Medical License 2021 - 2024
  • American Board of Allergy and Immunology Allergy & Immunology
  • Join now to see all

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy Therapies  
    Matthew Greenhawt, Marcus Shaker, Don A Bukstein, David M Fleischer, David R Stukus, Annals of Allergy, Asthma & Immunology
  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy  
    Todd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA

Other

Authored Content

  • Development and Acceptability of a Shared Decision-Making Tool for Commercial Peanut Allergy TherapiesFebruary 2020

Press Mentions

  • Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies
    Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE StudiesAugust 22nd, 2020
  • Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy: The PEPITES Randomized Clinical Trial
    Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy: The PEPITES Randomized Clinical TrialMarch 12th, 2020
  • DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020
    DBV Technologies to Present Detailed Safety and Efficacy Data of Viaskin Peanut at AAAAI 2020February 24th, 2020
  • Join now to see all

Professional Memberships

Hospital Affiliations